Report cover image

IPS Cell Derived Organoids Market Research Report Information by Type (Brain Organoids, Heart Organoids, Lung Organoids, Liver Organoids, Kidney Organoids, and Others), by Application (Drug Discovery and Development, Disease Modelling, and Regenerative Me

Publisher Market Research Future
Published Nov 21, 2024
Length 101 Pages
SKU # RESFT19406561

Description

IPS Cell Derived Organoids Market Research Report Information by Type (Brain Organoids, Heart Organoids, Lung Organoids, Liver Organoids, Kidney Organoids, and Others), by Application (Drug Discovery and Development, Disease Modelling, and Regenerative Medicine), by End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Contract Research Organization), and by Region (North America, Europe, Asia-Pacific, and Rest of the World Industry Forecast till 2032


The IPS Cell Derived Organoids Market was valued at USD 0.44 billion in 2023. The IPS Cell Derived Organoids Market is expected to increase from USD 0.51 billion in 2024 to USD 1.89 billion by 2032, with a compound yearly growth rate (CAGR) of 17.8% over the forecast period (2024-2032).

The IPS cell-derived organoids industry represents a paradigm shift in biomedical research and medication development. These small, three-dimensional tissue models created using induced pluripotent stem cells (iPSCs) provide unparalleled opportunities for investigating human physiology, disease processes, and medication efficacy. Organoids are employed in a variety of fields, including disease modeling, drug discovery, personalized medicine, and regenerative therapies. The market for iPS cell-derived organoids is expected to increase significantly, driven by technical advancements, rising desire for personalized treatment, and expanding applications in drug discovery and regenerative medicine. However, overcoming technical, legislative, and ethical barriers will be critical to realize the transformative technology's full potential.

Market Segment insights
Brain Organoids, Heart Organoids, Lung Organoids, Liver Organoids, Kidney Organoids, and Others are the type segments of the IPS Cell Derived Organoids Market.
The IPS Cell Derived Organoids Market is divided into three applications: drug discovery and development, disease modeling, and regenerative medicine.

Market Regional Insights
The IPS Cell Derived Organoids market in America has a strong research infrastructure, significant investments in life sciences, and a booming biotechnology industry. North America is home to several world-class colleges and research institutions at the forefront of stem cell research. This region has received significant expenditures from both the public and private sectors to advance the research and implementation of iPS cell-derived organoids. North America's well-established healthcare systems make sophisticated medical technologies more easily adopted. The presence of sophisticated laboratory facilities and qualified workers contributes to market expansion. The region's proclivity for technological adoption has facilitated the creation and implementation of organoid-based platforms. Supportive regulatory environments stimulate investment in organoid research and development.

The European IPS Cell Derived Organoids market accounted for the second-largest market share due to the region's concentration on healthcare, combined with a strong scientific community, which drives the market. Furthermore, the Germany IPS Cell Derived Organoids supplier is said to have the greatest market share, while the France IPS Cell Derived Organoids provider is expected to have the fastest growing market in the Europe area.

The Asia-Pacific IPS Cell Derived Organoids market is predicted to grow the fastest between 2023 and 2032, owing to increased investments in biomedical research, rising healthcare expenditure, and an increasing prevalence of chronic diseases, all of which can help IPS Cell Derived Organoids development.

Major Players
ACROBiosystems (US), Miltenyi Biotec (Germany), ThermoFisher Scientific (US), STEMCELL Technologies (Canada), Bio-Techne (US), Merck KGaA (Germany), Molecular Devices, LLC (US), Corning Incorporated (US), Promega Corporation (US), and Creative Bioarray (US) are among the major players in the IPS Cell Derived Organoids market.

Table of Contents

101 Pages
1 Executive Summary
2 Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.3 Research Objective
2.4 Market Structure
3 Research Methodology
3.1 Overview
3.2 Data Flow
3.2.1 Data Mining Process
3.3 Purchased Database:
3.4 Secondary Sources:
3.4.1 Secondary Research Data Flow:
3.5 Primary Research:
3.5.1 Primary Research Data Flow:
3.5.2 Primary Research: Number Of Interviews Conducted
3.5.3 Primary Research: Regional Coverage
3.6 Approaches For Market Size Estimation:
3.6.1 Revenue Analysis Approach
3.7 Data Forecasting
3.7.1 Data Forecasting Technique
3.8 Data Modeling
3.8.1 Microeconomic Factor Analysis:
3.8.2 Data Modeling:
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Growing Adoption Of Personalized Drugs
4.2.2 Rising Prevalence Of Chronic Diseases
4.2.3 Advancements In Stem Cell Research
4.2.4 Driver Impact Analysis
4.3 Restraints
4.3.1 High Cost Of Organoid Development And Maintenance
4.3.2 Regulatory Hurdles And Standardization
4.3.3 Restraint Impact Analysis
4.4 Opportunity
4.4.1 Development Of More Complex And Functional Organoids
4.4.2 Expansion Of Applications In Drug Discovery And Toxicology
4.5 Impact Analysis Of Covid -
4.5.1 Impact On Overall Health Industry
4.5.2 Impact On Global Ips Cell-derived Organoids Market
4.5.3 Impact On Supply Chain Of Ips Cell-derived Organoids
4.5.4 Impact On Market Demand Of Ips Cell-derived Organoids
4.5.5 Impact On Pricing Of Ips Cell-derived Organoids
5 Market Factor Analysis
5.1 Porter’s Five Forces Model
5.1.1 Threat Of New Entrants
5.1.2 Bargaining Power Of Suppliers
5.1.3 Bargaining Power Of Buyers
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Supply Chain Analysis
5.2.1 Raw Material
5.2.2 Production Process
5.2.3 Distribution
5.2.4 End User
6 Global Ips Cell-derived Organoids Market, By Type
6.1 Overview
6.2 Brain
6.3 Heart
6.4 Lung
6.5 Liver
6.6 Kidney
6.7 Others
7 Global Ips Cell-derived Organoids Market, By Application
7.1 Overview
7.2 Drug Discovery And Development
7.3 Disease Modelling
7.4 Regenerative Medicine
8 Global Ips Cell-derived Organoids Market, By End User
8.1 Overview
8.2 Pharmaceutical And Biotechnology Companies
8.3 Academic And Research Institutes
8.4 Contract Research Organization
9 Global Ips Cell-derived Organoids Market, By Region
9.1 Overview
9.1.1 Global Ips Cell-derived Organoids Market, By Region, 2020–
9.2 North America
9.2.1 North America: Ips Cell-derived Organoids Market, By Country, 2020–
9.3 Europe
9.3.1 Europe: Ips Cell-derived Organoids Market, By Country, 2020–
9.4 Asia Pacific
9.4.1 Asia Pacific: Ips Cell-derived Organoids Market, By Country, 2020–
9.5 Rest Of The World
9.5.1 Rest Of The World: Ips Cell-derived Organoids Market, By Country, 2020–
10 Competitive Landscape
10.1 Introduction
10.2 Major Growth Strategy In The Global Ips Cell-derived Organoids Market
10.3 Competitor Dashboard
11 Company Profiles
11.1 Acrobiosystems
11.1.1 Company Overview
11.1.2 Financial Overview
11.1.3 Products Offered
11.1.4 Key Developments
11.1.5 Swot Analysis
11.1.6 Key Strategies
11.2 Miltenyi Biotec
11.2.1 Company Overview
11.2.2 Financial Overview
11.2.3 Products Offered
11.2.4 Key Developments
11.2.5 Swot Analysis
11.2.6 Key Strategies
11.3 Thermofisher Scientific
11.3.1 Company Overview
11.3.2 Financial Overview
11.3.3 Products Offered
11.3.4 Key Developments
11.3.5 Swot Analysis
11.3.6 Key Strategies
11.4 Stemcell Technologies
11.4.1 Company Overview
11.4.2 Financial Overview
11.4.3 Products Offered
11.4.4 Key Developments
11.4.5 Swot Analysis
11.4.6 Key Strategies
11.5 Bio-techne
11.5.1 Company Overview
11.5.2 Financial Overview
11.5.3 Products Offered
11.5.4 Key Developments
11.5.5 Key Strategies
11.6 Merck Kgaa
11.6.1 Company Overview
11.6.2 Financial Overview
11.6.3 Products Offered
11.6.4 Key Developments
11.6.5 Swot Analysis
11.6.6 Key Strategies
11.7 Molecular Devices, Llc
11.7.1 Company Overview
11.7.2 Financial Overview
11.7.3 Products Offered
11.7.4 Key Developments
11.7.5 Key Strategies
11.8 Corning Incorporated
11.8.1 Company Overview
11.8.2 Financial Overview
11.8.3 Products Offered
11.8.4 Key Developments
11.8.5 Key Strategies
11.9 Promega Corporation
11.9.1 Company Overview
11.9.2 Financial Overview
11.9.3 Products Offered
11.9.4 Key Developments
11.9.5 Key Strategies
11.10 Creative Bioarray
11.10.1 Company Overview
11.10.2 Financial Overview
11.10.3 Products Offered
11.10.4 Key Developments
11.10.5 Key Strategies
List Of Tables
Table 1 Qfd Modeling For Market Share Assessment
Table 2 Global: Ips Cell-derived Organoids Market, By Type, 2019–2032 (Usd Million)
Table 3 Global: Ips Cell-derived Organoids Market, By Application, 2019–2032 (Usd Million)
Table 4 Global: Ips Cell-derived Organoids Market, By End User, 2019–2032 (Usd Million)
Table 5 Global Ips Cell-derived Organoids Market, By Region, 2019–2032 (Usd Million)
Table 6 North America: Ips Cell-derived Organoids Market, By Country, 2019–2032 (Usd Million)
Table 7 North America: Ips Cell-derived Organoids Market, By Type, 2019–2032 (Usd Million)
Table 8 North America: Ips Cell-derived Organoids Market, By Application, 2019–2032 (Usd Million)
Table 9 North America: Ips Cell-derived Organoids Market, By End User, 2019–2032 (Usd Million)
Table 10 Usa: Ips Cell-derived Organoids Market, By Type, 2019–2032 (Usd Million)
Table 11 Usa: Ips Cell-derived Organoids Market, By Application, 2019–2032 (Usd Million)
Table 12 Usa: Ips Cell-derived Organoids Market, By End User, 2019–2032 (Usd Million)
Table 13 Canada: Ips Cell-derived Organoids Market, By Type, 2019–2032 (Usd Million)
Table 14 Canada: Ips Cell-derived Organoids Market, By Application, 2019–2032 (Usd Million)
Table 15 Canada: Ips Cell-derived Organoids Market, By End User, 2019–2032 (Usd Million)
Table 16 Europe: Ips Cell-derived Organoids Market, By Country, 2019–2032 (Usd Million)
Table 17 Europe: Ips Cell-derived Organoids Market, By Type, 2019–2032 (Usd Million)
Table 18 Europe: Ips Cell-derived Organoids Market, By Application, 2019–2032 (Usd Million)
Table 19 Europe: Ips Cell-derived Organoids Market, By End User, 2019–2032 (Usd Million)
Table 20 Germany: Ips Cell-derived Organoids Market, By Type, 2019–2032 (Usd Million)
Table 21 Germany: Ips Cell-derived Organoids Market, By Application, 2019–2032 (Usd Million)
Table 22 Germany: Ips Cell-derived Organoids Market, By End User, 2019–2032 (Usd Million)
Table 23 Uk: Ips Cell-derived Organoids Market, By Type, 2019–2032 (Usd Million)
Table 24 Uk: Ips Cell-derived Organoids Market, By Application, 2019–2032 (Usd Million)
Table 25 Uk: Ips Cell-derived Organoids Market, By End User, 2019–2032 (Usd Million)
Table 26 France: Ips Cell-derived Organoids Market, By Type, 2019–2032 (Usd Million)
Table 27 France: Ips Cell-derived Organoids Market, By Application, 2019–2032 (Usd Million)
Table 28 France: Ips Cell-derived Organoids Market, By End User, 2019–2032 (Usd Million)
Table 29 Italy: Ips Cell-derived Organoids Market, By Type, 2019–2032 (Usd Million)
Table 30 Italy: Ips Cell-derived Organoids Market, By Application, 2019–2032 (Usd Million)
Table 31 Italy: Ips Cell-derived Organoids Market, By End User, 2019–2032 (Usd Million)
Table 32 Spain: Ips Cell-derived Organoids Market, By Type, 2019–2032 (Usd Million)
Table 33 Spain: Ips Cell-derived Organoids Market, By Application, 2019–2032 (Usd Million)
Table 34 Spain: Ips Cell-derived Organoids Market, By End User, 2019–2032 (Usd Million)
Table 35 Rest Of Europe: Ips Cell-derived Organoids Market, By Type, 2019–2032 (Usd Million)
Table 36 Rest Of Europe: Ips Cell-derived Organoids Market, By Application, 2019–2032 (Usd Million)
Table 37 Rest Of Europe: Ips Cell-derived Organoids Market, By End User, 2019–2032 (Usd Million)
Table 38 Asia Pacific: Ips Cell-derived Organoids Market, By Country, 2019–2032 (Usd Million)
Table 39 Asia Pacific: Ips Cell-derived Organoids Market, By Type, 2019–2032 (Usd Million)
Table 40 Asia Pacific: Ips Cell-derived Organoids Market, By Application, 2019–2032 (Usd Million)
Table 41 Asia Pacific: Ips Cell-derived Organoids Market, By End User, 2019–2032 (Usd Million)
Table 42 China: Ips Cell-derived Organoids Market, By Type, 2019–2032 (Usd Million)
Table 43 China: Ips Cell-derived Organoids Market, By Application, 2019–2032 (Usd Million)
Table 44 China: Ips Cell-derived Organoids Market, By End User, 2019–2032 (Usd Million)
Table 45 India: Ips Cell-derived Organoids Market, By Type, 2019–2032 (Usd Million)
Table 46 India: Ips Cell-derived Organoids Market, By Application, 2019–2032 (Usd Million)
Table 47 India: Ips Cell-derived Organoids Market, By End User, 2019–2032 (Usd Million)
Table 48 Japan: Ips Cell-derived Organoids Market, By Type, 2019–2032 (Usd Million)
Table 49 Japan: Ips Cell-derived Organoids Market, By Application, 2019–2032 (Usd Million)
Table 50 Japan: Ips Cell-derived Organoids Market, By End User, 2019–2032 (Usd Million)
Table 51 South Korea: Ips Cell-derived Organoids Market, By Type, 2019–2032 (Usd Million)
Table 52 South Korea: Ips Cell-derived Organoids Market, By Application, 2019–2032 (Usd Million)
Table 53 South Korea: Ips Cell-derived Organoids Market, By End User, 2019–2032 (Usd Million)
Table 54 Australia: Ips Cell-derived Organoids Market, By Type, 2019–2032 (Usd Million)
Table 55 Australia: Ips Cell-derived Organoids Market, By Application, 2019–2032 (Usd Million)
Table 56 Australia: Ips Cell-derived Organoids Market, By End User, 2019–2032 (Usd Million)
Table 57 Rest Of Apac: Ips Cell-derived Organoids Market, By Type, 2019–2032 (Usd Million)
Table 58 Rest Of Apac: Ips Cell-derived Organoids Market, By Application, 2019–2032 (Usd Million)
Table 59 Rest Of Apac: Ips Cell-derived Organoids Market, By End User, 2019–2032 (Usd Million)
Table 60 Rest Of The World: Ips Cell-derived Organoids Market, By Country, 2019–2032 (Usd Million)
Table 61 Rest Of World: Ips Cell-derived Organoids Market, By Type, 2019–2032 (Usd Million)
Table 62 Rest Of World: Ips Cell-derived Organoids Market, By Application, 2019–2032 (Usd Million)
Table 63 Rest Of World: Ips Cell-derived Organoids Market, By End User, 2019–2032 (Usd Million)
Table 64 Middle East & Africa: Ips Cell-derived Organoids Market, By Type, 2019–2032 (Usd Million)
Table 65 Middle East & Africa: Ips Cell-derived Organoids Market, By Application, 2019–2032 (Usd Million)
Table 66 Middle East & Africa: Ips Cell-derived Organoids Market, By End User, 2019–2032 (Usd Million)
Table 67 South America: Ips Cell-derived Organoids Market, By Type, 2019–2032 (Usd Million)
Table 68 South America: Ips Cell-derived Organoids Market, By Application, 2019–2032 (Usd Million)
Table 69 South America: Ips Cell-derived Organoids Market, By End User, 2019–2032 (Usd Million)
Table 70 Acrobiosystems: Products Offered
Table 71 Acrobiosystems: Key Developments
Table 72 Miltenyi Biotec: Products Offered
Table 73 Thermo Fisher Scientific Inc: Products Offered
Table 74 Stemcell Technologies: Products Offered
Table 75 Bio-techne Corp: Products Offered
Table 76 Merck Kgaa: Products Offered
Table 77 Molecular Devices.: Products Offered
Table 78 Corning Incorporated: Products Offered
Table 79 Promega Corporation.: Products Offered
Table 80 Creative Bioarray: Products Offered
List Of Figures
Figure 1 Global Ips Cell-derived Organoids Market: Structure
Figure 2 Market Dynamics: Global Ips Cell-derived Organoids Market
Figure 3 Driver Impact Analysis: Global Ips Cell-derived Organoids Market
Figure 4 Restraint Impact Analysis: Global Ips Cell-derived Organoids Market
Figure 5 Porter’s Five Forces Analysis: Global Ips Cell-derived Organoids Market
Figure 6 Supply Chain Analysis: Global Ips Cell-derived Organoids Market
Figure 7 Global Ips Cell-derived Organoids Market, By Type, 2023 (% Share)
Figure 8 Global Ips Cell-derived Organoids Market, By Type, 2019–2032 (Usd Million)
Figure 9 Global Ips Cell-derived Organoids Market, By Application, 2023 (% Share)
Figure 10 Global Ips Cell-derived Organoids Market, By Pricing, 2019–2032 (Usd Million)
Figure 11 Global Ips Cell-derived Organoids Market, By End User, 2023 (% Share)
Figure 12 Global Ips Cell-derived Organoids Market, By Age Category, 2019–2032 (Usd Million)
Figure 13 Global Ips Cell-derived Organoids Market, By Region, 2023 (% Share)
Figure 14 Global Ips Cell-derived Organoids Market, By Region, 2019-2032 (Usd Million)
Figure 15 North America: Ips Cell-derived Organoids Market Share, By Country, 2023 (% Share)
Figure 16 Europe: Ips Cell-derived Organoids Market Share, By Country, 2023 (% Share)
Figure 17 Asia Pacific: Ips Cell-derived Organoids Market Share, By Country, 2023 (% Share)
Figure 18 Middle East & Africa: Ips Cell-derived Organoids Market Share, By Country, 2023 (% Share)
Figure 19 Competitor Dashboard: Global Ips Cell-derived Organoids Market
Figure 20 Acrobiosystems: Swot Analysis
Figure 21 Miltenyi Biotec: Swot Analysis
Figure 22 Thermo Fisher Scientific Inc: Financial Overview Snapshot
Figure 23 Thermo Fisher Scientific Inc: Swot Analysis
Figure 24 Stemcell Technologies: Swot Analysis
Figure 25 Merck Kgaa: Financial Overview Snapshot
Figure 26 Merck Kgaa: Swot Analysis
Figure 27 Corning Incorporated: Financial Overview Snapshot

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us